Shareholders that Lost Money on TransMedics Group, Inc. (TMDX) Should Contact Levi & Korsinsky About Pending Class Action - TMDX
NEW YORK, NY / ACCESS Newswire / March 12, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...
Le Lézard19h
Investors who lost money on TransMedics Group, Inc.(TMDX) should contact Levi & Korsinsky about pending Class Action - TMDX
Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") of a class action securities ...
TMDX ALERT: TransMedics Group Investors are Notified of the Securities Fraud Class Action and are Urged to Contact BFA Law before Imminent Deadline
New York, New York-- (Newsfile Corp. - March 11, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...
Down 62%. Should You Buy TransMedics Stock on the Dip?
It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about ...
Le Lézard2d
TMDX INVESTOR DEADLINE: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. publicly traded securities between February 28, 2023 and January 10, 2025, both dates inclusive (the ...
TMDX CLASS ACTION ALERT: Transmedics Group, Inc. Is Being Sued In Connection With Its Business Practices – Contact Robbins LLP For Information
On this news, the price of TransMedics stock fell $3.74 per share, or 5.15%, to close at $68.81 on January 10, 2025. On January 13, 2025, TransMedics stock fell a further $4.76 per share, or 6.9%, to ...
AHA/ASA Journals5d
Clinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry
BACKGROUND: A preservation system, the Organ Care System (OCS; TransMedics) uses normothermic pulsatile perfusion during organ transport for heart transplantation. This system has demonstrated ...
A Closer Look At TransMedics Group's Earnings
NasdaqGM:TMDX Earnings and Revenue History March 7th 2025 A Closer Look At TransMedics Group's Earnings. One key financial ratio used to measure how well a company converts its pr ...
William Blair Lifts Earnings Estimates for TransMedics Group
Equities research analysts at William Blair raised their Q3 2025 earnings estimates for shares of TransMedics Group in a ...
Transmedics Group (TMDX) Plunges Amidst Allegations Of Fraud, Organ Trafficking – Hagens Berman
This report further depressed the company's stock price, the lawsuit claims. Prominent investor rights firm Hagens Berman Sobol Shapiro LLP is probing whether TransMedics misled investors regarding ...
TransMedics: Aggressive Guidance Largely Ignored By The Market
TransMedics' strong Q4 performance and market share growth signal a promising future for investors. Click here to find out ...
The Bakersfield Californian12d
ROSEN, THE FIRST FILING FIRM, Encourages TransMedics Group, Inc. Investors to Secure Counsel ...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive ...